In this guest editorial, Dr. Courtney Noah, BioIVT's Vice President of Scientific Affairs, explores why disease state donors and purified immune subsets improve predictive safety models
Programme to focus on advancement of animal-replacement technologies and transition towards human-first, AI-driven drug discovery
Against a backdrop of rising global obesity, researchers trace brown fat to an unexpected embryonic source
Recognizing the most impactful technologies and content across the drug discovery and development pipeline, as voted for by scientists worldwide
Every biomarker in Aliri’s study-ready panels is carefully selected and rigorously verified for its intended biological context
In this guest editorial, Creative Biolabs introduces its integrated human CNS modeling solutions that have been designed to accelerate the discovery of novel neurotherapeutics
Discover how researchers are using the LUNA-FX7™ automated cell counter to deliver precision and compliance in modern biopharma workflows
First commercially available NK (natural killer) cell-specific promoter library enables precise and controllable gene expression
Next-generation medium delivers up to 61% higher titers1, faster workflows, and greater flexibility for insulin-dependent CHO cell lines
Crown Bioscience to deliver clinical-grade testing, further strengthening its support for clients' clinical and translational drug development efforts
This collaboration is working to accelerate development of next-generation basophil activation testing
Integration of firefly liquid handling platform and SemaCyte microcarriers enables flexible, miniaturized, and automated cell assay workflows
The development of these potent inhibitors of the CBM signalosome complex, shows promising results by demonstrating apoptosis and tumor growth inhibition
Strategic collaboration to innovate Treg and TIL therapies, streamline cell therapy workflows, and enhance manufacturing efficiency
Built-in incubation, automated imaging, and AI-ready data generation deliver in vivo fidelity at scale
Generates deeper insights into inter-species differences to de-risk development pipelines and minimize animal testing
Waters has acquired Halo Labs™ to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies
New solutions from Siemens Healthineers address labs’ environmental and efficiency goals
From synthetic biology to microbiome and food safety research, the QPix FLEX system gives researchers the power to accelerate discovery, reduce hands-on time, and streamline their entire microbial screening process
Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate 'A Festival of Life Science'
Redipor by AnalytiChem combining 150+ years of expertise in high-quality prepared media, now manufactured in three production facilities worldwide
Innovation follows $1 million FARE Award
